pirfenidone has been researched along with Lung Injury, Acute in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Gareeb, AI; Al-Kuraishy, HM; Batiha, GE; Faidah, H; Saad, HM; Simal-Gandara, J | 1 |
| Chang, C; Du, Y; Fang, X; Gao, Y; Li, H; Li, T; Mu, M; Qin, X; Qu, G; Wang, X; Wang, Y; Xu, G; Yu, S; Zhang, Z; Zhu, P | 1 |
| Dai, M; Hu, C; Hu, Y; Li, H; Li, Q; Li, Y; Liu, S; Long, Y; Mao, Z; Pan, P; Song, C; Su, X; Tan, H; Wu, D; Zhang, L | 1 |
1 review(s) available for pirfenidone and Lung Injury, Acute
| Article | Year |
|---|---|
Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals.
Topics: Acute Lung Injury; COVID-19 Drug Treatment; Fibrosis; Goals; Humans; Pulmonary Fibrosis; Respiratory Distress Syndrome; SARS-CoV-2 | 2022 |
2 other study(ies) available for pirfenidone and Lung Injury, Acute
| Article | Year |
|---|---|
Pirfenidone alleviates lipopolysaccharide-induced lung injury by accentuating BAP31 regulation of ER stress and mitochondrial injury.
Topics: Acute Lung Injury; Alveolar Epithelial Cells; Animals; Apoptosis; Cells, Cultured; Disease Models, Animal; Endoplasmic Reticulum Stress; Gene Knockdown Techniques; Humans; Lipopolysaccharides; Male; Membrane Proteins; Mice; Mitochondria; Primary Cell Culture; Pulmonary Alveoli; Pyridones; Respiratory Distress Syndrome | 2020 |
Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Caspase 1; Cell Line; Fibrosis; Inflammasomes; Interleukin-1beta; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Pneumonia; Pyridones; Reactive Oxygen Species; Transforming Growth Factor beta1 | 2018 |